Delhi HC: Bipolar Disorder Alone Does Not Qualify as Medical Disability Without Benchmark Criteria  ||  Kerala HC: Excommunicating Knanaya Catholics For Marrying Outside the Community is Unconstitutional  ||  Kerala HC: Temporary Use of Religious Land For Public Infrastructure is Not a ‘Transfer’ under Law  ||  P&H HC: Habeas Plea in Child Custody Case Not Maintainable if Child is With Natural Guardian and Safe  ||  Delhi HC: Illegal Termination Does Not Automatically Entitle Employee to Reinstatement or Back Wages  ||  Gujarat High Court: Forcing Toddler to Attend Court 6 Hours Weekly For Grandfather Visits is Unjust  ||  Supreme Court Rejects Sameer Wankhede’s Plea, Directs Timely Resolution of Disciplinary Proceedings  ||  Supreme Court Rejects NHAI Review on Solatium Retrospectivity, Bars Reopening Settled Claims  ||  SC: Excise Duty Exemptions Based on Intended Use Must be Construed Liberally For Assessee  ||  Supreme Court: DSC Personnel Eligible For Second Pension; Allows Condonation of Shortfall    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved